Hey, good afternoon everyone. Charlie written, vice president for research, scholarship and innovation. Welcome to the April 2022 research town hall. As always, it's great to have you joining us. Have a really exciting program today. As always, let me start by sharing my screen and reminding everyone that our monthly virtual town halls are recorded so they're posted online after for those that can't join us and wanted to access some of the programming. It is available online. Today's program, I have just have a few quick announcements, so we've got a very exciting panel discussion with you, I guess Swami from our Office of Economic Innovation and partnerships and brief faculty inventors to share their experiences and taking their intellectual property ideas from, from idea to execution to incorporation in the marketplace and a whole variety of ways. While the few usual COVID-19 updates, research updates. And as always, please feel free to use the zoom function to ask your questions as we move through today's program. First, just a couple of announcements, really excited to now see it received an e-mail late last week that the EU Dari program, the UT anti-racism initiative, as announced to faculty summer scholars. Professor Kish, of course, are from the Department of English and assistant professor and Dr. accretion use an assistant professor in Sociology and Criminal Justice will be serving as are you Dari, faculty Summer Scholars this summer, so terrible, we'll hear more from them. And I should also point out that at the May research town hall, we will receive a presentation from the EU, the anti-racism initiative leadership team. So we're looking for that programming in May next month. As folks I'm sure are aware, at Earth Month at AUD last week was was Earth Day robust programming available all across our campuses. And I encourage you to access the programming that's available. But the UT homepage in particular, I draw your attention to a couple of events. One at the end of May, which is our annual ad day coming back full force on April 30th. And then made nine is a Presidential Symposium and teach and on climate change and sustainability. So lots of opportunities to engage across our campuses on this very broad and important topic. Also, in May, we'll be hosting our yearly Jefferson life sciences lecture. This year. We're fortunate to welcome professor named Carol Robinson from the University of Oxford. Professor Robinson also is receiving Franklin Medal Award in chemistry this year. So she'll be in our midst in the Philly New York area. The first part of next week, she will be giving a live lecture which is available either in person or in Zoom. Registration required on the link below. At 3PM. May second at Mitchell Hall and preceding that, and you can also access details of the program is a virtual symposium throughout the day with culminates with or live lecture and Mitchell Hall and a reception. Thereafter. I encourage you to register and participate. Always one of the highlights of the year, the difference in life sciences lecture. Also next week on, on Tuesday be the Bohr metal award ceremony has been held at the star Audi on it's an entire afternoon event, as you can see on the slide picture on the right is our colleague, Karl, or for whom the awards are named. One of our esteemed colleagues, we lost corals several years ago now, the boar metal metals awards. Now there are two. This is the first year 2. We're being handed out both for senior scholar at an earlier career scholar. An addition on Tuesday the 3rd at the star Audi on we will also have a ceremony to celebrate the 50th anniversary of the founding of the Institute for Energy Conversion here at the University of Delaware. And as you can see, all of that followed by a reception. So registration is required and RSVP's are requested by Wednesday of this week. So please access this link and register for the the boar Awards and the IAC 50th anniversary celebration. And Commencement is coming up very quickly as we know, culminating on May 28th with President Biden speaking at the UT Commencement in UD stadium. All of the events this year require tickets. So graduates guests must have tickets to attend the commencement convocation ceremonies. And so I encourage you to access details available at the commencement website on the UT homepage to ensure that tickets are secured and procured. A timely fashion. And as we transition into our presentation today, I want to start by highlighting some exciting new leadership we have in the Office of Economic Innovation and partnerships. New leadership in that office, but not a new leader to the University of Delaware for nearly five years. Dr. Julius coyly has been leading Innovation and Entrepreneurship in the College of Engineering. And so earlier this month, Julius was announced as the new Associate Vice President overseen our Office of Economic Innovation and partnerships, which includes activities and technology transfer, which will be the focus, some focus of this afternoon's panel presentation, as well as OAEP also hosts the Delaware Small Business Development Center and the Delaware Procurement Technical Assistance Center. Such great to have Julia continue in UT's campus community and to lead activities coming out of our Office of Economic Innovation Partnership. Julius is quite a, an insightful and visionary leader and entrepreneur. And so it's great to have someone with his breadth of experience and background leading 0, we IP through its next lifecycle. And so with that, I will turn it over to Joy Goswami, who was also in the Office of Economic Innovation and partnerships. Joy, as many of you know, serves as the Assistant Director of Technology Transfer. I'm Joy will be moderating this afternoon's panel, which will go for about 20 minutes. And he will also be introducing our panelists as I've shown on the slide here. But rather than looking at the slide of their static pictures, I will stop sharing my screen so that you can see joy, AJ, Amy, and harsh in Live In Living Color. So jet joy, turn it over to you. Sure. Thank you so much already. I hope everyone can hear me. Okay. Let me just begin by letting you all know that this panel today is going to be a very interesting panel because they are all successful folks that have been engaged in the process of technology transfer. But I cannot begin this session, of course, by not emphasizing what the importance of technology transfer is and by definition, what technology transfer really is. So for many of you that may have already worked in our office, started already worked in the tech transfer space. You probably know what it is, but needless to say, I need to define it. And so if I were to define tick transmits the process of translating knowledge and research into impact for the society and the economy. And so to basically hone it down to something simple, technology transfer is bringing impactful research to the marketplace. So whether you know, technology transfer, not everybody, I'm sure, has been impacted positively by tech transfer. And to just put it in perspective, if you're wearing the N95 mask, you'll have to attribute University of Tennessee for developing it. If you talk about the vaccines and the booster doses that you got for COVID. Or you'll have to attribute many universities, including the University of Oxford at that technology came from there. If you had, by any chance, honey crisp apples for lunch today came from University of Minnesota. If you use Internet on planes. So the mainland. And you can attribute University of Delaware for something that is very ubiquitous from our tech transfer standpoint, which is the touchscreen technology. So, so many of you who may not be aware that touchscreen technology, which is right now in every electronic device, has been impact of technology transfer coming from University of Delaware. Similarly, for on an annual basis, more than 800 plus products comes into the marketplace every year from academic research and technology transfer. And as many as 1000 plus new start-ups are created on an annual basis in this country to tech transfer. So like I mentioned, if you haven't heard of tech transfer, it's one thing, but if you if if you have not been positively impacted from technology transfer, that'll be something that'll be surprising because you all have. So it kind of really is existing all around us all the time. The way the mechanism works is university scientists while performing research, when they hit upon something that has commercial legs, they come to our office and it's upon us to try and assist these, these scientists to take those innovations into consideration, put some prediction around it by virtue of finding patents or trademarks or copyrights. And then seeking for collaborators that can assist with taking this technology into the marketplace. And in order to do so, there are two vehicles that we use. The first of which is by basically collaborating with companies that can bring these technologies to the marketplace or assisting with the faculties in starting their own businesses around it. So the three panelists today that I have are, like I said, have been very impactful in the University of Delaware Community. Egypt facade, Amy, cockpits were in harsh. And I'm going to actually take the discussions to them and have AJ, Amy and harsh maybe introduce themselves initially and then provide us with some sense of what innovations that are developed for UT. So let's go in this order, aging ME and Hirsch. And I turn it over to to to Asia to begin. A tanker, joy and good afternoon everybody. My name is AJ person. I'm a professor of mechanical engineering and I'm currently serving as department chair. So the innovation developed by my team is called a variable area ejector or hydrogen recirculation and fuel cell systems. In a little bit more detail, our design recirculates hydrogen, unused hydrogen from the outlet of the cell back to the inlet. But it does it passively without any moving parts. It consumes almost no power in its operation. And it is also highly resistant to corrosion. So in this way, it is superior to incumbent technology that is being used for the same purpose. My name is Amy convert weight. I am the co-director of the health care theater program at the University of Delaware, which basically means I sit in the College of Health Sciences, but I also am a faculty member in the School of Nursing. What technology I brought to market was a wearable, wearable simulators. It's for healthcare simulation specifically. So basically if you think of a healthy person and we want to make them less healthy, rather than cutting holes in their neck or sticking them repeatedly with needles. The wearable simulators allow the patient to react and respond in real time, but they are not being injured or harmed in any way. And so that allows the students to practice on more complex cases without having them do it at the bedside on a real patient. Thanks Joy. My name is harsh base. I'm an Associate Professor and Department of plants or assassinate sizes and College of Ag. Though the technology that we brought several years back and now part of it is different versions of it as an already in the market and commercial market is inoculum that we are working on for last several years. This is basically a microbial inoculum which promotes growth and also protect plants against lot of diseases. So it's kind of an alternative approach that's been talked about for last several years, rather a decade. But our technology kind of came in right time because it could be seed coded and then it could pry the plant against different kind of stresses. Thank you so much Is a Hershey and Amy. So this introduction was very helpful hopefully for the audience, but I'm going to actually have some specific questions for you. And as a direct these precedence obviously feel free to any of you that I'm not directing you to feel free to respond as well, but maybe just for the for the general public that would never ever worked in the tech transfer field. And I'm drifting, dispersed into Asia. And maybe to begin with, the process of tech transfer really begins with the faculty member coming to their respective tech transfer offices. In this case the VIP office. And what we do is when you come and knock that Adobe give you asked you to fill up an invention disclosure form. You complete, which is a short form. And then after completing the form, you, you basically start the process and we review it and then the interaction and collaboration of tech transfer starts. So the onus really is somewhat upon you as an inventor to come to our office. Because obviously you do a lot of research. Is it can you just walk us through when you, in your, in due course of time thought that this is about time that you have an invention really that VIP tech transfer office should take a look at. And in doing so where you precluded from publishing. Because obviously the general psychology of many faculty members is publish or perish. So was there anything that you felt that would be impacted in your publication? And then when do you think you went, did you think was the right thing to countless. Walk us through the story if you can. Yeah, certainly. So we have a AuD tills have bus program on our campus. And the first bus arrived here on our campus into 2007. And within a year of deploying that first bus, the onboard hydrogen recirculate are that was installed on the bus by the manufacturer, failed due to corrosion by hydrogen. And we sourced or replacement part, but it does prohibit doubly expensive. So at that time, we asked our master's student to see if they could restart some alternatives. And that student identified the ejector as a technology but good potential phone. We developed our own unique innovations around this ejector idea. We built a prototype, we installed on our bus, and we found that it worked perfectly. And that's when we realized we had developed a product that had some commercial value and some commercial potential. So around that time, we approached or EIP, and then we filed a provisional patent application in 2010. In terms of publishing this idea, the provisional patent application gives you immediate protection. So once you have the provisional find, you are free to publish in a journal or a conference. And that's exactly what we did. We submitted a manuscript around that time which got published in the International Journal of hydrogen energy. And that was, I think, just couple of years after the provisional application. So in 2012, our paper came out and not paper received a lot of citations as well. So you can actually do both. You can engage in IP sharing as well as in publication. Thank you so much easier. So from sounds, if it didn't look as though you had an IPO problems and publishing it. And in some respects, I think that the culture was that you came to us first, we protected it, and then you are free to publish it, do whatever you did from an academic, academic standpoint. So that's, that's very important and that's usually one of the common myths that we want to demystify with. Many faculty members feel that publication is an issue, but I think I want to reinforce the fact that you're coming to her office and filing for an IP protection doesn't have any impact whatsoever in, in your publication. So overall, the process is fairly seamless, except this one little, it'll aspect of your coming and getting pattern file. And also for the general public. When the patent actually gets published, which usually happens within 18 months of its filing. This patent application itself acts as a publication. So it kind of has a positive impact engine. Okay, anyway, I turn around. Thank you everybody. For Amy. While when you came to our office, obviously, you had an innovation and we obviously are evaluation of the lines. I don't always pan out all you want to get. The gentlemen. I don't know if I'm ever basically replicate the pasture and I know I'm having I'm distracted. Three. Okay. Steve Steve, could you put yourself on mute, please. Thank you. I'm so sorry. Yeah. Alright. Thank Andrew. I am sorry. Let let me just go back and tell you that. So when when you came to our office with an invention disclosure, obviously, we had to make an assessment of the value of the invention. So the evaluation is very important. So obviously, your perception of the value was very important and we took that into consideration. But upon doing the evaluation, we had one of two ways of trying and seeing how best to commercialize it. One was to let you start a business around it and the other was to see if there was any company that was interested to take this technology on and, and commercialize it. You choose to do a startup around it. Can you just walk us through what motivated you to start a business around it and you, and your feeling that the technology would best be doing justice by virtue of your starting the business and going into the hands of the consumers. Yeah. So first of all, I did not initially choose to like to start my own company. I wanted the products to be licensed because I love my job at the University of Delaware and I love what I'm doing. And I felt that I know that I couldn't do both. And that's not true, but but but in the time I didn't have any confidence with starting a company or are helping the company get started. I didn't know what was all involved with it. So I did choose initially licensing it. But what ended up happening was there was two events that triggered this. One was we had definitely some early interests from other men, mannequin based companies, companies. We're already on the market. They came to visit but they never responded back. We never heard from them. And then the second was that I heard and I don't know if it was you told me joy or David told me. But somebody told me that a lot of times people will license the product and then it sits on the shelf, but it doesn't get out. They just use the glycines it so that basically no one's going to buy their products. Or that that case, if they feel threatened, they're going to license it and then just leave it on the shelf and nobody has it. And I just firmly believed that this was such a much better way to teach healthcare students. That I could not imagine that this technology would sit on a shelf for 17 years to avoid it getting out. And so my mama said, tell me that there's something she can't do and she'll figure out how to do it. And that's pretty much pretty much what happened to the situation. I listen to 250 books on business and we end up in off we went. But I I would I would have to say that it didn't it didn't just happen overnight. And it didn't happen with a lot of help and support from the university. So it's not just the technology transfer, it's also also with the horn program is doing with the I4 program and all of that. So it's not just this is done and then you have to go figure it all out. You still get a lot of support from the university. And I didn't realize how vital that wasn't till I've seen other companies that try outside the bounds of university support. And I'm very thankful that, that our products are that the anti-gay rights are licensed from the University of Delaware. I mean, we still have that plug-in power and support. That's wonderful, Amy, thanks so much for the feedback and, and for the perspective of again, for listeners who come to do tech transfer with us, obviously the first process is to come to our office, but after the fact that we take the technology into consideration for commercialization, whatever path is best suited for it to get commercialized. Work as one big happy family and the UD community. So there's many sister offices of VIP including the home program, the SBDC, and several others in and around. Even outside the university, that we provide a lot of assistance for startups and Amy, from the sounds of it, you got that good enough. Insistence 70 eventually choose to start your own business and still do. And I don't know. Yes, That's great. Any regrets in the hindsight now that you decided to take your mom's advice, huh? Well, I got my PhD, but I liken it to that. I don't know if it's garbage here, but you absolutely have to be passionate about the technology and passionate about what you're doing because it's not sprint, it's a marathon. So I would just say no that you don't if you're not absolutely in love with it, I wouldn't move forward and know that it is going to be a long process. It's not, it's not in two years, you're profitable and everything's perfectly fine. You've got, you've got a road ahead of you. But it's, it's, I have learned so much. I have gained so much wisdom and knowledge, not just in the technology, had, not just in running a business, but also with leadership. And again, I wouldn't change it, but I was It's definitely yeah, I had changed from being and as ful full-on sprint 2 and now adjusting to the marathon. Dixon. Thank you so much, Amy, turning around harsh. Maybe I'll just pose the question to you are a little bit of an outlier from the two other panelists in that pure technology got acquired by a Fortune 500 company, BASF. And then eventually we ended up doing a lot with the company and also in some respects, have a lot of academic corporate alliances with them. So harsh, could you just walk us through the process and of commercialization and what other benefits you've got with working with BASF such as corporate funding maybe or sponsored research. So I think it just like everybody else's Pat, I guess we were working on something very fundamental where we had a bacteria which we're showing up a lot of promises in terms of promoting growth in plants, protecting plants against various different type of diseases and other abiotic stress. But I think the next step, as rightly pointed out by Ajahn, Amy is was was basically talking with you guys at OAEP and there were you guys were really helpful in terms of kind of understanding that you really can protect or rather patterned light bacterium, but definitely protect the traits that you're getting in plants. So that was the invention part. And this was very timely because the whole concept, or rather the whole field of microbiome was opening up in plants. And, and at the right time, I guess BSF was we kind of shared all these, but this was not possible without the initial help that we got from VIP and also from DBI. To be very frank. And in terms of the credit that's due in terms of Kelvin actually Kevin, Kevin Lee from DBI kind of helped us also in a way to kind of generate more greenhouse datasets. And that was done through a grant funding that came through and and then we had enough to basically show it too short for the pattern. And then BSF came on board. Actually, BSF was also very serendipitous in a way because we originally our original discussion swerve. It's a very small company called as Becker Underwood, which makes biological inoculants mainly for legumes. And Becker Underwood was acquired by BASF. And then BSF came into discussions. Being a large company, being a chemical company. They were very, very clear in terms of what they wanted. A point to now where they have replaced our inoculum with the top inoculum. So with BASF, I think the biggest advantage that I've seen over time is this just how progressive they are and they are basically thinking ahead for the next product in terms of how we can modify this particular strain, not engine injure the strain, but by doing different kind of combinatorial stuff. So working with them is definitely a plus because, you know, you, you are basically discussing basic science and trying to see how better it could be in terms of going to the field. Thank you so much inertia. And again, from the sounds of it, I think all three of you have been pleasantly happy with the way things worked in. And we're glad that in the process are in our philosophy of trying to put the technology that you have invented into the, into the hands of the consumers. We've been fairly successful and, and I'm hoping that in the process you've also been rewarded well enough. And you felt that this was worth your value of time to eventually come to your office to get everything done. So before I wind up and hand it over to Charlie, any closing thoughts? So maybe I'll go through Jamie and then Harsh. Any any thoughts you have for the for the audience to listen into? Yeah, certainly, I would say filing the invention disclosure and a provisional patent application is actually quick and easy. For us academics. It's far easier than submitting a manuscript or a journal. I can really attest to that. The provisional application gives you one full year to develop the idea, to gather more data. And during that one year, you're also free to publish at conferences and journals. So at the end of that one year, we are filed the full patent. And it took, I don't know, another three years for the patent to get published. But now we have patent protection and North America and Europe and in Japan. So we did it for the first patent as well as on what tattered. And then what are we IPs encouragement and help. We also started our own company and we, every year we now develop custom prototypes for automotive OEMs worldwide. We found a VIP very helpful in starting the company. They found us local law firm and Burlington to help with the whole process of setting up an LLC. It was really, really easy. And it's been a very exciting and rewarding journey for me personally to have done this. Thanks so much to me. I would echo ij's sentiments as far as the process. I am not an HD, but I didn't find that process too daunting. But when I did need help, You guys were there to help. So it's not as if you're on your own to fill this out of your questions. You guys had we had the OH, we are very much in hand. What willing to help. The other thing that I would say is DO file an invention disclosure. If it does go to where you're filing for a full-on, that you pay very close attention to the to the especially to the very first claim that is made, um, but, but to all of the claims because what happens, and this is, again, not aware at all. What happens is if you create other ideas that revolve around this first one, there's, there's umbrella patents that go underneath. So that very first one that you file, it's really important that once the lawyers make up make up the the the actual filing, that you you really watch it closely and make sure that it is exact, specific as they can be, but as broad as it can be at the same time. You want it to be as broad as it possibly can be because an a cover the most. So that'll be my only other piece of advice for people who are just initially picking at it. Shouldn't. Thanks. Amy Hirsch of one last thing I think I agree. Man, terms of how painless the provisions are, it's very easy to follow them. Kind of gives you protection. Also kind of gives you a liberty or freedom of publishing it. But then right after that, and masters are harder to write than the professionals. One important aspect that I've learned, licensing through a big company is, is that you can actually work with them and they're ready to work with you in terms of visa sponsorship, sponsorship projects. So you know, they are there to kind of develop the technology and they are willing to actually go and support a grasp to render a post-doc in the lab is going to help you develop this technology further. So that part was, was kind of really, really promising and beneficial for us and we'll be certainly, as pointed out, was, was really helpful both for instance, sponsorship project that we had with BASF and also in terms of making that pattern very broader now that we have this particular technology and production in different parts of the world for this, uh, for our technology, I think GIP also played a very crucial role in terms of making it broader and joy perceived just because he's a plant pathologist. So he knows, at least for me. I was very, very beneficial. So they think someone's Harrison and again, from, from the standpoint of the tech transfer professional, and I've been doing this for about 15 years now. There's nothing more rewarding than to see the seeds of all success in the hands of consumers. So when you send pictures of your products, when we put it up on a website, when we use this as a success stories, It's a great feeling. And, and again, there are a lot of moving parts. It takes time. It's not something that happens overnight as all the speakers mentioned. But at the end of the day, I think it's themed back that is more important and just not, isn't just the impact in terms of us giving back to the, to, to you as inventors. But the amount of impact we do to the society, to the nation in general, and to the world globally speaking for many, to technology that go around the world is important. So it's a very rewarding process. But again, I do want to reinforce nothing begins until you come to our office and give us the disclosure. So VIP handles roughly anywhere between 30 to 15 mentioned disclosure their beer. But it is upon you that you as inventors, as scientists come to us at the time and you feel that there is something a value. And then we take the, the, the invention then to the next step and then the process begins. So once again, I would like to thank you all harsh AJ and Amy for your wonderful insights. As a disclaimer, this program was not sponsored by VIP, So I think everything that came came out of your heart and we really appreciate the support provided and all the great things that you have provided to the society. And we look forward to continuing to work with you. Thanks very much and I turned round to Charlie. Thanks so much joy and congratulations to do a great job moderating that that panel. I mean, I was struck by the, the breadth of the topics, certainly from, from three different academic colleges, but also showing the diversity of journeys an adventure can take to bring their discoveries to the marketplace. So really appreciate that help, but that wet a number of people's appetite for thinking about how to have impact with your scholarship here at the University of Delaware and some of the resources that are available. So I will go back to sharing my screen. And in doing so, the next slide on the presentations for today, which again will be available online, is a list of individuals to contact. I'm headed, as I mentioned by Julius quarterly has now the associated BP early IP individuals in the tech transfer office. I'm Joy and his colleagues, Lu De Na, who's a point of contact and the Small Business Development Center. And something that we didn't talk about, but I think is very important and quite robust here at UT is our commercialization committee which meets regularly to evaluate on intellectual property that that comes in to the office. Evaluate how best to protect that intellectual property, how to get it to a place where it's well-positioned for societal impact, commercialization and monetization. So we really appreciate the work of that broader group which, which includes our broad UD community that's involved. And that's the last point I wanted to mention before we transition back to our regular programming, if you will. And that is the linkage between this presentation, the work that's going on with commercialization, and the recently announced refresh your strategic plan. Which of course, folks will recall that one of the five pillars is named redefining creativity, innovation and entrepreneurship. And so ensuring that we've got robust infrastructure to support these activity is our faculty, staff and students is really consistent with the mission of our research university. So now let me give you a few updates with respect to COVID on campus and across the region. So we continue to be in relatively, relatively speaking, low transmission statistics as indicated on the top of this slide, much lower than the last spike, which was the macron variant between December and February or so. As of this morning, the positivity rate in the state of Delaware is 7.6%. That compares relative to the positivity rates. When we last met in January, February, and March and March it was 3.1%. I will note though, that the testing has also diminished rather significantly both within the state and, and across campus. As you will see. Importantly, the hospitalization numbers continue to be lower than they have been. And thankfully the number of individuals in ICU is is quite well. But of course, any any numbers more than we'd like to see, because those are sickest community members, friends, and neighbors. On campus, we continue to have experienced relatively good numbers. And here you can see along this plot, since we began our surveillance testing campus, the last full week, for which we have data, there were about 70 positive cases. And that's a combination of both employees and students. Just as a reminder, masking is no longer required indoors in non-classroom spaces. But we are continuing to expect vaccination and testing requirements for our visitors. Travel as we talked about last time, as open back up. And so the travel forms that we're very familiar with for much of the last two years are no longer required, but we certainly expect that our travelers will be up-to-date with their vaccinations prior. To traveling. And then I think very importantly, as we've also talked about a fair bit throughout the pandemic and particularly recently. They're members of our community for whole variety of reasons, may choose to continue to wear masks. And even though in environments where that's not required. And I think it's important as part of the campus community that we respect the decisions of all. Whether they wear a mask or not. Just a reminder about some other protocols that continue to be in place. Masking is required in classroom settings are childcare facilities. And while on UD sponsored transportations, I heard this morning that we're going through our shuttle buses, for example, are going through masks quite at a high, quite a high rate. Because I think as folks are moving about campus and non-classroom settings and being less rigorous with bringing masks with them. They find themselves in need of a mass with now have one when they jump on one of the shuttle buses. So the buses do have masks available on the UD health screen. Check that ball tracts. We encourage it expects students, employees, and visitors to continue to use those. For the balance of the spring semester. I'm testing the surveillance testing for asymptomatic individuals. Continues Harker I slab four days a week, Monday through Thursday. So registration is required available at this link. As mentioned last month, the pink header site has been closed. The last day for testing at Harker ice lab will be made 26. And at this time there are no plans for summer surveillance testing. And so as more information becomes available with respect testing and other COVID mitigation protocols. For the summer. Those updates will be communicated broadly across campus. And with that, I will close again by thanking joy Goswami. Amy cope with weight, AJ Poseidon and harsh space for their very engaged panel discussion. And I will turn it over to Tracy Brian, Senior Director research communications on the off chance we have any questions that need to be addressed. Tracy, anything come in? Well, nothing has come in so far, Charlie. Fantastic. That I wouldn't be happy to answer questions that folks have. The maybe give folks a minute here. Folk vote. Absolutely. We'll give folks a minute before we remind everyone that we will be convening again on Monday, May 16th. And our special guests, as I mentioned earlier, will be the leadership of the University of Delaware anti-racism initiative to talk about the myriad programming that they have been developing since they were launched a year and a half or more now? Ago now. Yeah, it looks like we have a question in here now, Charlie. Okay. Question is the daily survey seems like the least useful of the possible mitigation approaches, but seems to be the only one remaining. Is there any chance that that will be changed sale. So couple of thoughts there. As we've always talked about. It's it's a layered strategies. So every mitigation strategy builds upon others. And so we continue to get guidance that there continues to be valid value in reminding folks to think about their health status on a daily basis when they come to campus. That that having been said, as I mentioned earlier, the we will be revisiting all of these mitigation strategy at the end of the spring semester and when we have updates to to share, those will be shared. But I think it's I think it's safe to say that we will be revisiting the value of the call trucks daily survey as we head into the summer and next fall. Okay. Great. Thank you, Charlie. Okay. Well, we do have a note in here. I don't know if everybody's saying it in the chat, but AJ facade is asking everyone to unleash your inner entrepreneur and that we Ip will help you every step of the way. Fantastic. Thank you very much for that. Aj. I think that's a great note to end on. So we will call it the end of our time together for this month. Look forward to seeing everyone on campus a minute coming few weeks, and the next town hall in May and commencement at the end of May. So take care all.
COVID-19 Town Hall 4-25-2022
From David Barczak April 25, 2022
11 plays
11
0 comments
0
You unliked the media.
A town hall hosted on April 25, 2022, provides important updates for the UD research community, from campus operations to grants administration, and ways you can help our local community at this time.
- Tags
- Department Name
- Research Office
- Date Established
- April 25, 2022
- Appears In
Link to Media Page
Loading
Add a comment